GL1X · GenesisL1 explorer

MolNFT v1 · #133113 · protein

Pandda analysis group deposition -- crystal structure of SARS-cov-2 helicase in complex with Z53116498

5RLT: “Pandda analysis group deposition -- crystal structure of SARS-cov-2 helicase in complex with Z53116498”. X-ray diffraction, 3 ligands (UVJ, ZN, PO4), 13 pockets (best druggability 0.75). MolNFT v1 #133113 on GenesisL1: 3D structure…

PDB
5RLT
Type
protein
Length
1,157 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Helicase
EC
3.6.4.12, 3.6.4.13
UniProt
P0DTD1
Ligands
UVJ, ZN, PO4
Pockets
13 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHelicase (EC 3.6.4.12, 3.6.4.13)protein57231% helix, 23% strandP0DTD1
BHelicase (EC 3.6.4.12, 3.6.4.13)protein58529% helix, 24% strandP0DTD1

Ligands and binding sites

  • UVJ · 3-(2-methyl-1H-benzimidazol-1-yl)propanamide · ligand · chains B
  • ZN · Zinc ion · metal · 6 copies · chains A, B
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14000.750.8545empty
22620.710.8641empty
33540.650.8040empty
42660.630.8131empty
51320.600.8628PO4

Interfaces

1 interface between chains.

  • A–B · 698 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 5RLT · PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.